Action to Control Cardiovascular Risk in Diabetes (ACCORD) "ACCORD"


Phase 3 Results

Summary of Purpose

The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 April 2016.

1 Sep 1999 27 Oct 1999 1 Jun 2009 1 Dec 2012 1 Nov 2014 5 Sep 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Factorial Assignment


Not available